Bleeding events in patients with acute coronary syndrome (ACS) are associated with poor outcomes. Risk factors and their associations with in-hospital events in older patients with ACS are not fully understood because older ...
May 25, 2023
0
12
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency.
Nov 1, 2022
0
7
The doctoral dissertation of Annika Piirainen, Lic Med, explores the dosage, administration and related adverse events of three non-steroidal anti-inflammatory drugs (NSAIDs), dexketoprofen, etoricoxib and ibuprofen, in postoperative ...
Aug 11, 2021
0
3
(HealthDay)—For patients with multiple myeloma (MM), those with renal insufficiency (RI) have an increased risk for disease progression or death, according to a systematic review and meta-analysis published online Jan. ...
Jan 22, 2021
0
3
(HealthDay)—From 2003-2007 to 2013-2017, there was an improvement in survival for allogeneic hematopoietic cell transplantation, according to a study published online Jan. 21 in the Annals of Internal Medicine.
Jan 21, 2020
0
1
RUDN University physicians have proposed a method for diagnosing the dangerous heart disease AL-amyloid cardiopathy. Until now, doctors could detect it only in the later stages, when treatment is not possible. The results ...
Jan 20, 2020
0
450
(HealthDay)—Adherence to heart failure process of care measures has improved significantly over the last 10 years for patients with acute decompensated heart failure with reduced ejection fraction (HFrEF) and end-stage ...
May 17, 2016
0
3
The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and ...
Apr 8, 2016
0
1
In Germany, nearly 2 million people have non-dialysis-dependent renal insufficiency. This is the result presented by Matthias Girndt and colleagues, based on a study from the Robert Koch Institute and published in Deutsches ...
Feb 29, 2016
0
2
Belatacept (trade name: Nulojix) has been approved since June 2011 for adults after a kidney transplant. It is used together with other drugs to prevent the body from rejecting the transplanted organ. After a first early ...
Oct 21, 2015
0
14
